Placement Announced
Processa Pharmaceuticals placement
US$200m raised
Announced 29 Jul 2026 · NASDAQ: PCSA · US$1221.19 cash per share
Advisers
Processa Pharmaceuticals
Issuer
Not disclosed
Lead managers
- Issuer
- Processa Pharmaceuticals
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- Silence Therapeutics placement Aug 2026 · US$201m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- AbCellera Biologics equity raising Aug 2026 · US$200m · Biotech
- Apnimed IPO Jul 2026 · US$192m · Biotech

